These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26312645)

  • 1. Five potential therapeutic agents as antidepressants: a brief review and future directions.
    Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU
    Expert Rev Neurother; 2015; 15(9):1015-29. PubMed ID: 26312645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond serotonin: newer antidepressants in the future.
    Rakesh G; Pae CU; Masand PS
    Expert Rev Neurother; 2017 Aug; 17(8):777-790. PubMed ID: 28598698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying fast-onset antidepressants using rodent models.
    Ramaker MJ; Dulawa SC
    Mol Psychiatry; 2017 May; 22(5):656-665. PubMed ID: 28322276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Criticisms of drugs in early development for the treatment of depression: what can be improved?
    Wang SM; Han C; Pae CU
    Expert Opin Investig Drugs; 2015 Apr; 24(4):445-53. PubMed ID: 25529224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT7 receptor antagonists as a new class of antidepressants.
    Mnie-Filali O; Lambás-Señas L; Zimmer L; Haddjeri N
    Drug News Perspect; 2007 Dec; 20(10):613-8. PubMed ID: 18301795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Anti-Depressive Treatment Maneuvers from Bench to Bedside.
    Cai M; Wang H; Zhang X
    Adv Exp Med Biol; 2019; 1180():277-295. PubMed ID: 31784969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relationship between Fatty Acids and Different Depression-Related Brain Regions, and Their Potential Role as Biomarkers of Response to Antidepressants.
    Fernandes MF; Mutch DM; Leri F
    Nutrients; 2017 Mar; 9(3):. PubMed ID: 28304335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of muscarinic system with serotonin-norepinephrine reuptake inhibitor antidepressant attenuates depression in mice.
    Singh P; Singh TG
    Indian J Pharmacol; 2015; 47(4):388-93. PubMed ID: 26288470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatment of unipolar depression.
    Anderson IM
    Curr Top Behav Neurosci; 2013; 14():263-89. PubMed ID: 22544348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine and rapidly acting antidepressants: Breaking the speed of sound or light?
    Berk M; Loo C; Davey CG; Harvey BH
    Aust N Z J Psychiatry; 2018 Nov; 52(11):1026-1029. PubMed ID: 29952212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.
    Koike H; Iijima M; Chaki S
    Behav Brain Res; 2011 Oct; 224(1):107-11. PubMed ID: 21669235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theory of active antidepressants: a nonsynaptic approach to the treatment of depression.
    Kiss JP
    Neurochem Int; 2008 Jan; 52(1-2):34-9. PubMed ID: 17507113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of neurobiologic processes in treating depression.
    Thase ME
    J Clin Psychiatry; 2010 Oct; 71(10):e28. PubMed ID: 21062614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants.
    Köhler S; Cierpinsky K; Kronenberg G; Adli M
    J Psychopharmacol; 2016 Jan; 30(1):13-22. PubMed ID: 26464458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The potential of group II metabotropic glutamate receptor antagonists as a novel antidepressant].
    Chaki S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Aug; 32(4):219-26. PubMed ID: 23012890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
    Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
    CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating antidepressants of the future: efficacy and safety.
    Rosenzweig-Lipson S; Beyer CE; Hughes ZA; Khawaja X; Rajarao SJ; Malberg JE; Rahman Z; Ring RH; Schechter LE
    Pharmacol Ther; 2007 Jan; 113(1):134-53. PubMed ID: 17010443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine and other potential glutamate antidepressants.
    Dutta A; McKie S; Deakin JFW
    Psychiatry Res; 2015 Jan; 225(1-2):1-13. PubMed ID: 25467702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.